Asthmatic airway hyperresponsiveness: The ants in the tree

Trends in Molecular Medicine

Volumn 18, Issue 11, 2012, Pages 627-633

  Bossé, Ynuk ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Airway hyperresponsiveness; Airway smooth muscle; Asthma; Contractility; Force; Spasmogen

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACROLEIN; ACTIN; BACTERIUM LIPOPOLYSACCHARIDE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; COAL; COMPLEMENT COMPONENT C5A; ENDOTHELIN 1; FORMALDEHYDE; GLUCOCORTICOID; HISTAMINE; HOUSE DUST ALLERGEN; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; LEBRIKIZUMAB; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPOLIZUMAB; MYOSIN; NICOTINE; NITROGEN DIOXIDE; OZONE; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN D2; THROMBOXANE A2; TIOTROPIUM BROMIDE; TOBACCO SMOKE; UNINDEXED DRUG;

ASTHMA; BACTERIUM; BREATHING MUSCLE; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; EXTRACELLULAR MATRIX; FUNGUS; HUMAN; MUSCLE CONTRACTILITY; MUSCLE STRENGTH; NONHUMAN; POLLUTANT; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINOVIRUS; SMOOTH MUSCLE; TRACHEOBRONCHIAL TREE; WELDING FUME;

AIR POLLUTANTS; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; GLUCOCORTICOIDS; HUMANS; INFLAMMATION MEDIATORS; MUSCLE, SMOOTH; RESPIRATORY SYSTEM;

FORMICIDAE;

EID: 84868198872     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.09.002     Document Type: Review

References (64)

1. Masoli M., et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59:469-478.
2. Chin L.Y., et al. Mechanical properties of asthmatic airway smooth muscle. Eur. Respir. J. 2012, 40:45-54.
3. McParland B.E., et al. Airway wall remodeling: friend or foe?. J. Appl. Physiol. 2003, 95:426-434.
4. Damera G., et al. An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma. PLoS ONE 2012, 7:e28504.
5. Black J.L., et al. Airway smooth muscle in asthma: just a target for bronchodilation?. Clin. Chest Med. 2012, 33:543-558.
6. Shan X., et al. Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L324-L333.
7. Chiba Y., et al. Effect of cigarette smoke exposure in vivo on bronchial smooth muscle contractility in vitro in rats. Am. J. Respir. Cell Mol. Biol. 2005, 33:574-581.
8. Xu Y., et al. Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways. Respir. Res. 2010, 11:13.
9. Berntsen P., et al. Biomechanical effects of environmental and engineered particles on human airway smooth muscle cells. J. R. Soc. Interface 2010, 7(Suppl. 3):S331-S340.
10. Grunstein M.M., et al. Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle. J. Allergy Clin. Immunol. 2005, 116:94-101.
11. Chiba Y., et al. SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. J. Pharmacol. Sci. 2010, 114:304-310.
12. Cai Y., et al. Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats. Int. Immunol. 2011, 23:443-451.
13. Grunstein M.M., et al. Autocrine cytokine signaling mediates effects of rhinovirus on airway responsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 278:L1146-L1153.
14. Grunstein M.M., et al. Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection. J. Allergy Clin. Immunol. 2001, 108:997-1004.
15. Bachar O., et al. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-κB signaling pathways. Eur. J. Immunol. 2004, 34:1196-1207.
16. Cooper P.R., et al. Involvement of IL-13 in tobacco smoke-induced changes in the structure and function of rat intrapulmonary airways. Am. J. Respir. Cell Mol. Biol. 2010, 43:220-226.
17. Murlas C., Lee H.K. U-60,257 inhibits O3-induced bronchial hyperreactivity in the guinea pig. Prostaglandins 1985, 30:563-572.
18. Setoguchi H., et al. Leukotriene C(4) enhances the contraction of porcine tracheal smooth muscle through the activation of Y-27632, a rho kinase inhibitor, sensitive pathway. Br. J. Pharmacol. 2001, 132:111-118.
19. 2+ handling and Rho/ROCK signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L1177-L1184.
20. Sakai J., et al. Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells. J. Physiol. 2003, 549:171-180.
21. 2+ sensitization in extracellular adenosine triphosphate-induced hyperresponsiveness in airway smooth muscle. Clin. Exp. Allergy 2007, 37:893-900.
22. Morin C., et al. EET displays anti-inflammatory effects in TNF-α stimulated human bronchi: putative role of CPI-17. Am. J. Respir. Cell Mol. Biol. 2008, 38:192-201.
23. Kume H., et al. Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation. J. Pharmacol. Exp. Ther. 2007, 320:766-773.
24. Morin C., et al. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17kD in asthma. Am. J. Respir. Cell Mol. Biol. 2011, 45:366-375.
25. Jain D., et al. Essential role of IFNβ and CD38 in TNFα-induced airway smooth muscle hyper-responsiveness. Immunobiology 2008, 213:499-509.
26. Kudo M., et al. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 2012, 18:547-554.
27. 2+ sensitization of myosin light chain 20 phosphorylation. Mol. Pharmacol. 2003, 63:714-721.
28. Sakai H., et al. TNF-α augments the expression of RhoA in the rat bronchus. J. Smooth Muscle Res. 2004, 40:25-34.
29. Chiba Y., et al. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am. J. Respir. Cell Mol. Biol. 2009, 40:159-167.
30. Tliba O., et al. Tumor necrosis factor-α differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-β-dependent CD38 pathway. Mol. Pharmacol. 2004, 66:322-329.
31. 2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J. 2003, 17:452-454.
32. Deshpande D.A., et al. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am. J. Respir. Cell Mol. Biol. 2004, 31:36-42.
33. Goldsmith A.M., et al. Transforming growth factor-β induces airway smooth muscle hypertrophy. Am. J. Respir. Cell Mol. Biol. 2006, 34:247-254.
34. Deng H., et al. Inhibition of glycogen synthase kinase-3β is sufficient for airway smooth muscle hypertrophy. J. Biol. Chem. 2008, 283:10198-10207.
35. Nino G., et al. G protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma. PLoS ONE 2012, 7:e32078.
36. Nair P., et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 2009, 360:985-993.
37. Haldar P., et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 2009, 360:973-984.
38. Corren J., et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 2011, 365:1088-1098.
39. Peters S.P., et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N. Engl. J. Med. 2010, 363:1715-1726.
40. Bossé Y., Paré P.D. Airway smooth muscle responsiveness: the origin of airway hyperresponsiveness in asthma?. Curr. Respir. Med. Rev. 2011, 7:289-301.
41. Bachar O., et al. TNFα reduces tachykinin, PGE2-dependent, relaxation of the cultured mouse trachea by increasing the activity of COX-2. Br. J. Pharmacol. 2005, 144:220-230.
42. Whelan R., et al. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle. Eur. Respir. J. 2004, 24:559-567.
43. Grunstein M.M., et al. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L1130-L1137.
44. Laporte J.C., et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 2001, 164:141-148.
45. Ishikawa T., et al. Inhibitory effects of interferon-γ on the heterologous desensitization of β-adrenoceptors by transforming growth factor-β1 in tracheal smooth muscle. Clin. Exp. Allergy 2003, 33:808-815.
46. 2+ sensitization in airway smooth muscle. Allergol. Int. 2012, 61:311-322.
47. 2+ sensitization in tracheal smooth muscle. Am. J. Respir Cell Mol. Biol. 2001, 25:291-298.
48. 2+ mobilization in desensitization of β-adrenoceptors by platelet-derived growth factor in airway smooth muscle. Eur. J. Pharmacol. 2008, 591:259-265.
49. 2+ sensitization in tracheal smooth muscle. Clin. Exp. Allergy 2008, 38:135-144.
50. Eum S.Y., et al. IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L576-L584.
51. Goldsmith A.M., et al. Regulation of airway smooth muscle α-actin expression by glucocorticoids. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L99-L106.
52. Bossé Y., et al. It's not all smooth muscle: nonsmooth muscle elements in control of resistance to airflow. Annu. Rev. Physiol. 2010, 72:437-462.
53. Mazzone S.B., et al. Sympathetic nerve-dependent regulation of mucosal vascular tone modifies airway smooth muscle reactivity. J. Appl. Physiol. 2010, 109:1292-1300.
54. Bates J.H., et al. Airway responsiveness depends on the diffusion rate of methacholine across the airway wall. J. Appl. Physiol. 2012, 112:1670-1677.
55. Grainge C.L., et al. Effect of bronchoconstriction on airway remodeling in asthma. N. Engl. J. Med. 2011, 364:2006-2015.
56. King G.G., et al. Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT. Eur. Respir. J. 2004, 24:211-218.
57. Downie S.R., et al. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007, 62:684-689.
58. Vicente-Manzanares M., et al. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009, 10:778-790.
59. Zhang W., Gunst S.J. Interactions of airway smooth muscle cells with their tissue matrix: implications for contraction. Proc. Am. Thorac. Soc. 2008, 5:32-39.
60. Zhang W., Gunst S.J. Dynamic association between α-actinin and β-integrin regulates contraction of canine tracheal smooth muscle. J. Physiol. 2006, 572:659-676.
61. Huang Y., et al. Activation of vinculin induced by cholinergic stimulation regulates contraction of tracheal smooth muscle tissue. J. Biol. Chem. 2011, 286:3630-3644.
62. Tawhai M.H., et al. CT-based geometry analysis and finite element models of the human and ovine bronchial tree. J. Appl. Physiol. 2004, 97:2310-2321.
63. Bossé Y., et al. Adaptation of airway smooth muscle to basal tone: relevance to airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 2009, 40:13-18.
64. Pascoe C., et al. Force oscillations simulating breathing maneuvers do not prevent force adaptation. Am. J. Respir. Cell Mol. Biol. 2012, 47:44-49.